Warren Averett Asset Management, LLC Crispr Therapeutics Ag Transaction History
Warren Averett Asset Management, LLC
- $6.36 Billion
- Q4 2024
A detailed history of Warren Averett Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 15,495 shares of CRSP stock, worth $634,830. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,495
Previous 19,392
20.1%
Holding current value
$634,830
Previous $911,000
33.15%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$368 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$358 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$156 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$114 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$112 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.2B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....